Rising Healthcare Costs And Policy Risks Will Erode Margins
AN
AnalystLowTarget
Not Invested
Consensus Narrative from 14 Analysts
Published
13 Jul 25
Updated
30 Jul 25
AnalystLowTarget's Fair Value
US$153.00
0.5% undervalued intrinsic discount30 Jul
US$152.31
1Y
-54.5%7D
-4.8%